New Ballgame in Washington

Wechsler, Jill
January 2011
Pharmaceutical Representative;Jan2011, Vol. 41 Issue 1, p26
The article discusses issues concerning health care reform in the U.S. It details that the U.S. Congress represented by the Republicans plans for revision or repeal of the statute Affordable Care Act (ACT) from U.S. President Barack Obama's Obamacare program. It stresses that the pharmaceutical industry as well as biopharmaceutical manufacturers are affected by the implementation of the ACA due to changes in drug insurance coverage and cuts in federal funds for the industry.


Related Articles

  • Industry Leaders Pledge to Help Obama in Healthcare Reform Effort.  // Aging News Alert;5/15/2009, p4 

    The article reports that U.S. President Barack Obama stated that he would not rest until the dream of health care reforms is achieved, after receiving a pledge to help the country move towards a national healthcare plan, from the leading healthcare industry players. The president's statement...

  • With the election behind us, innovation to the fore. Mickelberg, Larry // Medical Marketing & Media;Dec2012, Vol. 47 Issue 12, p35 

    The author discusses the reemergence of health reform issues on the behind-the-scenes-deal between pharmaceutical industry and the U.S. government following the victory of President Barack Obama.

  • Pulling the Plug on Grandma. Czap, Al // Alternative Medicine Review;Sep2009, Vol. 14 Issue 3, p208 

    The author reflects on the disadvantages of the health care system and the negative implications of the health care reform proposed by U.S. President Barack Obama. He asserts that the health care system is broken and arrogant. He adds that some individuals consider the American Medical...

  • Healthcare Reform in the United States: Fact, Fiction and Drama. Qazi, Khalid J. // British Journal of Medical Practitioners;2009, Vol. 2 Issue 4, p5 

    The article presents the author's statements regarding the condition of healthcare reform in the U.S. It mentions the successful implementation of the medical care reform under President Barack H. Obama's administration. In addition, the author cites the actions and responses of several business...

  • The pharmaceutical industry faces unprecedented barriers to evolution.  // PharmaWatch: Monthly Review;Jun2009, Vol. 8 Issue 6, p37 

    The article reports on the existing problem in the pharmaceutical industry in the U.S. It notes that the industry is facing new challenges due to the global economic downturn and to the changes made by U.S. President Barack Obama on healthcare system in the country. Moreover, it suggests that...

  • Healthcare Reform and Medical Meetings. Pelletier, Sue // Medical Meetings;Jun2010, Vol. 37 Issue 4, p47 

    The article focuses on the Patient Protection and Affordable Care Act, a healthcare reform bill that was signed by U.S. President Barack Obama into law in March 2010. The Physician Payment Sunshine Provisions of the bill are expected to affect both pharmaceutical company meetings for healthcare...

  • The crisis of the US health care system and Obama's bill. SARGIS, JOHN // International Journal of Inclusive Democracy;Jan2010, Vol. 6 Issue 1, p1 

    The article presents the author's views regarding the crisis of the healthcare system in U.S. and the new bill of President Barack Obama on the health care reforms passed by the U.S. Senate and the U.S. Congress. According to the author, the U.S. democracy is controlled by the corporates and the...

  • Obama And The Supertanker. Brownstein, Ronald // National Journal;3/20/2010, p13 

    The article focuses on the health care reform plan bill in the U.S. Congress. President Barack Obama has pushed for the health care steadily and is willing to sacrifice politically. The article relates Obama's struggle with the plan as his long-term political strategy and a measure of success of...

  • Pharmaceutical Industry Outlook 2013. Howell, Peyton // Pharmaceutical Processing;Jan/Feb2013, Vol. 28 Issue 1, p20 

    The article discusses the outlook for the pharmaceutical industry in the U.S. in 2013. It explores the post-election impact to healthcare reform, health policy, and the continued implementation of the Patient Protection and Affordable Care Act (ACA) under the administration of reelected...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics